Reduction of prohibitin expression contributes to left ventricular hypertrophy via enhancement of mitochondrial reactive oxygen species formation in spontaneous hypertensive rats

References

• Sugden PH. Ras, Akt, and mechanotransduction in the cardiac myocyte. Circ Res 2003;93:1179–1192.
   PubMed Web of Science ®Google Scholar
• Kass DA, Bronzwaer J G, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004;94:1533–1542.
   PubMed Web of Science ®Google Scholar
• Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res 2002;90:1055–1063.
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003;92:139–150.
   PubMed Web of Science ®Google Scholar
• Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 2004;322:1178–1191.
   PubMed Web of Science ®Google Scholar
• De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW II, et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res 2000;86:255–263.
   PubMedGoogle Scholar
• Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 2006;103:7432–7437.
   PubMedGoogle Scholar
• Paolisso G, Galzerano D, Gambardella A, Varricchio G, Saccomanno F, D’Amore A, et al. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 1995;25:529–533.
   PubMedGoogle Scholar
• Li L, Yi-Ming W, Li ZZ, Zhao L, Yu YS, Li DJ, et al. Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats. Pharmacol Res 2008;58:196–201.
   PubMedGoogle Scholar
• Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, et al. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension 2006;48:225–231.
   PubMed Web of Science ®Google Scholar
• Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004;10:1200–1207.
   PubMed Web of Science ®Google Scholar
• Zhang X, Klein AL, Alberle NS, Norby FL, Ren BH, Duan J, Ren J. Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect. J Mol Cell Cardiol 2003;35:645–652.
   PubMedGoogle Scholar
• Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998; 98:794–799.
   PubMed Web of Science ®Google Scholar
• Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002;105:509–515.
   PubMed Web of Science ®Google Scholar
• Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001;89:453–460.
   PubMed Web of Science ®Google Scholar
• Aikawa R, Nagai T, Tanaka M, Zou Y, Ishihara T, Takano H, et al. Reactive oxygen species in mechanical stress-induced cardiac hypertrophy. Biochem Biophys Res Commun 2001; 289:901–907.
   PubMed Web of Science ®Google Scholar
• Ago T, Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal 2007;9: 679–687.
   PubMedGoogle Scholar
• Kuster GM, Siwik DA, Pimentel DR, Colucci WS. Role of rever-sible, thioredoxin-sensitive oxidative protein modifications in cardiac myocytes. Antioxid Redox Signal 2006;8:2153–2159.
   PubMedGoogle Scholar
• Murdoch CE, Zhang M, Cave AC, Shah AM. NADPH oxidasedependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 2006;71:208–215.
   PubMed Web of Science ®Google Scholar
• Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002;34:379–388.
   PubMed Web of Science ®Google Scholar
• Nakagami H, Takemoto M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 2003;35:851–859.
   PubMed Web of Science ®Google Scholar
• McLachlan J, Beattie E, Murphy MP, Koh-Tan CH, Olson E, Beattie W, et al. Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function. J Hypertens 2014;32:555–564.
   PubMed Web of Science ®Google Scholar
• Dai DF, Chen T, Szeto H, Nieves-Cintrón M, Kutyavin V, Santana LF, Rabinovitch PS. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 2011;58:73–82.
   PubMed Web of Science ®Google Scholar
• Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cochemé HM, et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009;54:322–328.
   PubMed Web of Science ®Google Scholar
• Gregory-Bass RC, Olatinwo M, Xu W. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis. Int J Cancer 2008;122:1923–1930.
   PubMed Web of Science ®Google Scholar
• Ikonen E, Fiedler K, Parton RG, Simons K. Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett 1995 358:273–277.
   PubMedGoogle Scholar
• Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Löwer B, Wunderlich FT, et al. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev 2008;22:476–488.
   PubMed Web of Science ®Google Scholar
• Kasashima K, Sumitani M, Satoh M, Endo H. Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids. Exp Cell Res 2008;314:988–996.
   PubMed Web of Science ®Google Scholar
• Schleicher M, Shepherd BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, et al. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 2008;180:101–112.
   PubMedGoogle Scholar
• Liu X, Ren Z, Zhan R, Wang X, Wang X, Zhang Z, et al. Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte. Cell Stress Chaperones 2009;14:311–319.
   PubMed Web of Science ®Google Scholar
• Zhou P, Qian L, D’Aurelio M, Cho S, Wang G, Manfredi G, et al. Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J Neurosci 2012;32:583–592.
   PubMed Web of Science ®Google Scholar
• Kathiria AS, Butcher LD, Feagins LA, Souza RF, Boland CR, Theiss AL. Prohibitin 1 modulates mitochondrial stress- related autophagy in human colonic epithelial cells. PLoS One 2012;7:e31231.
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Lei FY, Huang WF, Drummen GP. Prohibitin is associated with antioxidative protection in hypoxia/reoxygenation-induced renal tubular epithelial cell injury. Sci Rep 2013;3:3123.
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Lei FY, Huang WF, Drummen GP. Prohibitin attenuates oxidative stress and extracellular matrix accumulation in renal interstitial fibrosis disease. PLoS One 2013;8:e77187.
   PubMed Web of Science ®Google Scholar
• Kim N, Lee Y, Kim H, Joo H, Youm JB, Park WS, et al. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics 2006;6:1237–1249.
   PubMed Web of Science ®Google Scholar
• Chowdhury D, Tangutur AD, Khatua TN, Saxena P, Banerjee SK, Bhadra MP. A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats. J Transl Med 2013;11:130.
   PubMed Web of Science ®Google Scholar
• Sun B, Wang JH, Lv YY, Zhu SS, Yang J, Ma JZ. Proteomic adaptation to chronic high intensity swimming training in the rat heart. Comp Biochem Physiol Part D Genomics Proteomics 2008;3:108–117.
   PubMedGoogle Scholar
• Lord KC, Shenouda SK, McIlwain E, Charalampidis D, Lucchesi PA, Varner KJ. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res 2010;87:111–118.
   PubMed Web of Science ®Google Scholar
• Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 2003;21:1961–1967.
   PubMedGoogle Scholar
• Mariappan N, Soorappan RN, Haque M, Sriramula S, Francis J. TNF-α-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 2007; 293:H2726–H2737.
   PubMed Web of Science ®Google Scholar
• Schlüter KD, Piper HM. Isolation and culture of adult ventricular cardiomyocytes. In: Dhein S, Mohr F, Delmar M (eds.). Practical methods in cardiovascular research. Berlin: Springer; 2005. Pp. 557–567.
   Google Scholar
• Boveris A, Cadenas E, Stoppani AOM. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 1976;156:435–444.
   PubMed Web of Science ®Google Scholar
• Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973;134:707–716.
   PubMed Web of Science ®Google Scholar
• Jüllig M, Hickey AJ, Chai CC, Skea GL, Middleditch MJ, Costa S, et al. Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 2008;8:2556–2572.
   PubMed Web of Science ®Google Scholar
• Wikman-Coffelt J, Parmley WW, Mason DT. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ Res 1979;45: 697–707.
   PubMed Web of Science ®Google Scholar
• Muders F, Elsner D. Animal models of chronic heart failure. Pharmacol Res 2000;41:605–612.
   PubMed Web of Science ®Google Scholar
• McClung JK, Jupe ER, Liu XT, Dell’Orco RT. Prohibitin: potential role in senescence, development, and tumor suppression. Exp Gerontol 1995;30:99–124.
   PubMed Web of Science ®Google Scholar
• Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, Back JW, et al. Prohibitins act as a membrane bound chaperone for the stabilization of mitochondrial proteins. EMBO J 2000;19:2444–2451.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 2002;80:780–787.
   PubMed Web of Science ®Google Scholar
• Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, Cardol P, et al. Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin. Biochem J 2004;383: 491–499.
   PubMedGoogle Scholar
• Lijnen P, Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 1999;31:949–970.
   PubMed Web of Science ®Google Scholar
• Baker KM, Booz GW, Dostal DE. Cardiac action of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992;54: 227–241.
   PubMed Web of Science ®Google Scholar
• Zhang YH, Dingle L, Hall R, Casadei B. The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium. Biochim Biophys Acta 2009;1787: 811–817.
   PubMedGoogle Scholar
• De Giusti VC, Caldiz CI, Ennis IL, Pérez NG, Cingolani HE, Aiello EA. Mitochondrial reactive oxygen species (ROS) as signaling molecules of intracellular pathways triggered by the cardiac renin-angiotensin II-aldosterone system (RAAS). Front Physiol 2013;4:126.
   PubMed Web of Science ®Google Scholar
• AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001;276:39721–39726.
   PubMed Web of Science ®Google Scholar